153 related articles for article (PubMed ID: 7627148)
21. Technetium-99m mercaptoalbumin as a potential substitute or technetium-99m labelled red blood cells.
Verbeke KA; Vanbilloen HP; De Roo MJ; Verbruggen AM
Eur J Nucl Med; 1993 Jun; 20(6):473-82. PubMed ID: 8339730
[TBL] [Abstract][Full Text] [Related]
22. Preparation of the renal function and imaging agent 99mTc-MAG3 starting from S-unprotected mercaptoacetyltriglycine.
Noll B; Johannsen B; May K; Spies H
Int J Rad Appl Instrum A; 1992 Jul; 43(7):899-901. PubMed ID: 1321100
[TBL] [Abstract][Full Text] [Related]
23. Technetium-99m complexes of polydentate amine-pyrrole and amine-thiophene ligands.
Pillai MR; Samuel G; Banerjee S; Mathew B; Sarma HD; Jurisson S
Nucl Med Biol; 1999 Jan; 26(1):69-77. PubMed ID: 10096504
[TBL] [Abstract][Full Text] [Related]
24. Novel oxorhenium and oxotechnetium complexes from an aminothiol[NS]/thiol[S] mixed-ligand system.
Bouziotis P; Pirmettis I; Pelecanou M; Raptopoulou CP; Terzis A; Papadopoulos M; Chiotellis E
Chemistry; 2001 Sep; 7(17):3671-80. PubMed ID: 11575768
[TBL] [Abstract][Full Text] [Related]
25. Characterisation and biodistribution of two neutral 99mTc(CO)3 complexes with a tridentate ligand.
Rattat D; Cleynhens B; Bormans G; Terwinghe C; Verbruggen A
Bioorg Med Chem Lett; 2005 Oct; 15(19):4192-5. PubMed ID: 16084082
[TBL] [Abstract][Full Text] [Related]
26. Investigation of the labelling characteristics of 99mTc-mercaptoacetyltriglycine.
Bormans G; Cleynhens B; Adriaens P; Vanbilloen H; De Roo M; Verbruggen A
Nucl Med Biol; 1995 Apr; 22(3):339-49. PubMed ID: 7627149
[TBL] [Abstract][Full Text] [Related]
27. Human polyclonal immunoglobulin labelled with technetium-99m via NHS-MAG3: a comparison of radiochemical behavior and biological efficacy with other labelling methods.
Gano L; Patrício L; Marques E; Cantinho G; Pena H; Martins T; Hnatowich DJ
Nucl Med Biol; 1998 May; 25(4):395-403. PubMed ID: 9639302
[TBL] [Abstract][Full Text] [Related]
28. Development of novel mixed-ligand oxotechnetium [SNS/S] complexes as potential 5-HT1A receptor imaging agents.
Papagiannopoulou D; Pirmettis I; Maina T; Pelecanou M; Nikolopoulou A; Chiotellis E; Raptopoulou CP; Vlahos AT; Terzis A; Papadopoulos M; Chiotellis E
J Biol Inorg Chem; 2001 Mar; 6(3):256-65. PubMed ID: 11315561
[TBL] [Abstract][Full Text] [Related]
29. Characterization of technetium-99m complexes of pentane-2,4-dione bis(N-methylthiosemicarbazone).
Arano Y; Yabuki M; Jones AG; Yokoyama A
Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):104-7. PubMed ID: 2049793
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, characterization, and biological evaluation of (99m) Tc(CO)3 -labeled peptides for potential use as tumor targeted radiopharmaceuticals.
Baishya R; Nayak DK; Chatterjee N; Halder KK; Karmakar S; Debnath MC
Chem Biol Drug Des; 2014 Jan; 83(1):58-70. PubMed ID: 23679852
[TBL] [Abstract][Full Text] [Related]
31. Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation.
Stalteri MA; Mather SJ
Eur J Nucl Med; 1996 Feb; 23(2):178-87. PubMed ID: 8925853
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, characterization and biodistribution studies of a neutral-lipophilic Tc-99m N3S2 chelate.
Singh PR; Corlija M; Troutner DE; Ketring AR; Volkert WA
Int J Rad Appl Instrum B; 1992 Oct; 19(7):791-5. PubMed ID: 1399701
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, characterization and biodistribution of a new technetium-99m complex with trimethylsilylmethylisonitrile. Comparison with 99mTc-TBI and 99mTc-MIBI.
Bouquillon S; Coulais Y; Dartiguenave M; Tafani JA; Guiraud R
Nucl Med Biol; 1995 Jul; 22(5):585-8. PubMed ID: 7581167
[TBL] [Abstract][Full Text] [Related]
34. Oxorhenium(V) and oxotechnetium(V) [NN][S]3 complexes of 2-phenylbenzothiazole derivatives.
Tzanopoulou S; Pirmettis IC; Patsis G; Raptopoulou C; Terzis A; Papadopoulos M; Pelecanou M
Inorg Chem; 2006 Jan; 45(2):902-9. PubMed ID: 16411729
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of a new class of technetium-99m monocationic radiotracers from dithienyldiazalkanes.
Goomer NC; Kulkarni PV; Constantinescu A; Antich P; Parkey RW; Corbett JR
Nucl Med Biol; 1994 May; 21(4):657-62. PubMed ID: 9234324
[TBL] [Abstract][Full Text] [Related]
36. Technetium-99m DTPA dimethyl ester: a renal function imaging agent. Comparative studies in animals with technetium-99m mercaptoacetyl triglycine and 131I-ortho-iodohippurate.
Bhowal K; Bhattacharyya S; Majumdar A; Giri C; Vanaja R; Ramamoorthy N; Ganguly S; Sarkar BR; Banerjee S; Chatterjee Debnath M
Nucl Med Commun; 2003 May; 24(5):583-95. PubMed ID: 12717078
[TBL] [Abstract][Full Text] [Related]
37. Technetium-99m complex of N-(2-pyridylmethyl)iminodiacetic acid as a new renal radiopharmaceutical.
Karube Y; Iwamoto K; Takata J
Ann Nucl Med; 1999 Apr; 13(2):127-32. PubMed ID: 10355959
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of silylated mixed-ligand 99mTc complexes with the [PNS/S] donor atom set.
Fernandes C; Kniess T; Gano L; Seifert S; Spies H; Santos I
Nucl Med Biol; 2004 Aug; 31(6):785-93. PubMed ID: 15246370
[TBL] [Abstract][Full Text] [Related]
39. Specificity of diastereomers of [99mTc]TRODAT-1 as dopamine transporter imaging agents.
Meegalla SK; Plössl K; Kung MP; Stevenson DA; Mu M; Kushner S; Liable-Sands LM; Rheingold AL; Kung HF
J Med Chem; 1998 Feb; 41(4):428-36. PubMed ID: 9484494
[TBL] [Abstract][Full Text] [Related]
40. Chemical and biological evaluation of technetium (I) tricarbonyl complexes with EHIDA and DPD. 99m (I) complexes of EHIDA and DPD.
Djokić DDj; Janković DLj; Stamenković LLj; Pirmettis I
Nucl Med Rev Cent East Eur; 2004; 7(1):1-5. PubMed ID: 15318303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
